World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
44172
World Ranking
9139
National Ranking
4714

Overview

Alona Muzikansky is affiliated with Harvard University in the United States and has a research focus primarily within the field of Medicine, with a substantial number of publications addressing Oncology, Pulmonary and Respiratory Medicine, Neurology, Genetics, and Molecular Biology. Their work spans multiple topics related to cancer and neurological disorders.

The scientist's research interests prominently include:

  • Neurofibromatosis and Schwannoma Cases
  • Glioma Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Meningioma and schwannoma management
  • Brain Metastases and Treatment
  • Smoking Behavior and Cessation
  • Cancer Immunotherapy and Biomarkers

Muzikansky has contributed to several recent papers, notable for their relevance to neuro-oncology, cancer immunotherapy, and disease mechanism study. Among these publications are:

  • "Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer's disease" (2020), published in Nature Communications
  • "Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma" (2020), published in Clinical Cancer Research
  • "Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer" (2020), published in JAMA
  • "Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results" (2021), published in Neuro-Oncology
  • "A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor" (2021), published in Journal of Thoracic Oncology

The frequent publication venues for Muzikansky's work include:

  • Neuro-Oncology
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Neurology
  • bioRxiv (Cold Spring Harbor Laboratory)

There is a pattern of collaboration with several co-authors who have contributed extensively to similar research areas. These frequent collaborators include:

  • Scott R. Plotkin
  • Justin T. Jordan
  • Patrick Y. Wen
  • David A. Reardon
  • Elyse R. Park

Alona Muzikansky's work addresses critical issues in cancer treatment, neurological disorders, and behavioral health interventions related to smoking cessation, reflecting integration of molecular, clinical, and therapeutic research approaches. Their publication record indicates consistent contribution to oncology and neurology literature with interdisciplinary collaboration.

Best Publications

  • Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer

    Jennifer S. Temel;Joseph A. Greer;Alona Muzikansky;Emily R. Gallagher

  • Isolation of rare circulating tumour cells in cancer patients by microchip technology.

    Sunitha Nagrath;Lecia V. Sequist;Shyamala Maheswaran;Daphne W. Bell;Daphne W. Bell

  • Detection of Mutations in EGFR in Circulating Lung-Cancer Cells

    Shyamala Maheswaran;Lecia V. Sequist;Sunitha Nagrath;Lindsey Ulkus

  • First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic EGFR Mutations

    Lecia V. Sequist;Renato G. Martins;David Spigel;Steven M. Grunberg

  • Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

    A. D. Norden;G. S. Young;K. Setayesh;A. Muzikansky

  • Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial

    Jennifer S. Temel;Joseph A. Greer;Areej El-Jawahri;William F. Pirl

  • Effect of Early Palliative Care on Chemotherapy Use and End-of-Life Care in Patients With Metastatic Non–Small-Cell Lung Cancer

    Joseph A. Greer;William F. Pirl;Vicki A. Jackson;Alona Muzikansky

  • Tumor Lymphangiogenesis : A Novel Prognostic Indicator for Cutaneous Melanoma Metastasis and Survival

    Soheil S. Dadras;Thomas Paul;Jennifer Bertoncini;Lawrence F. Brown

  • Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors

    Matthew H. Kulke;Keith Stuart;Peter C. Enzinger;David P. Ryan

  • Perioperative CA19-9 Levels Can Predict Stage and Survival in Patients With Resectable Pancreatic Adenocarcinoma

    Cristina R. Ferrone;Dianne M. Finkelstein;Sarah P. Thayer;Alona Muzikansky

  • Phase II Study of Gemcitabine and Oxaliplatin in Combination With Bevacizumab in Patients With Advanced Hepatocellular Carcinoma

    Andrew X. Zhu;Lawrence S. Blaszkowsky;David P. Ryan;Jeffrey W. Clark

  • Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor

    Zofia Piotrowska;Matthew J. Niederst;Chris A. Karlovich;Heather A. Wakelee

  • The Prognostic Significance of Phosphatidylinositol 3-Kinase Pathway Activation in Human Gliomas

    Arnab Chakravarti;Gary Zhai;Yoshiyuki Suzuki;Sormeh Sarkesh

  • Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes

    Soheil S Dadras;Bernhard Lange-Asschenfeldt;Paula Velasco;Lynh Nguyen

  • The Effect of Surgery and Grade on Outcome of Gastrointestinal Stromal Tumors

    Jean Pierre E N Pierie;Umar H Choudry;Alona Muzikansky;Beow Yong Yeap

  • Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice

    L. V. Sequist;R. S. Heist;A. T. Shaw;P. Fidias

  • Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study

    Andrew X Zhu;Jeffrey A Meyerhardt;Lawrence S Blaszkowsky;Avinash R Kambadakone

  • EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

    Nicolas Marcoux;Scott N. Gettinger;Grainne O’Kane;Kathryn C. Arbour

  • Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses

    Tilak K. Sundaresan;Lecia V. Sequist;John Victor Heymach;Gregory J. Riely

  • Mucin-Producing Neoplasms of the Pancreas: An Analysis of Distinguishing Clinical and Epidemiologic Characteristics

    Stefano Crippa;Carlos Fernández–del Castillo;Roberto Salvia;Dianne Madelyn Finkelstein

Frequent Co-Authors

Patrick Y. Wen
Patrick Y. Wen Harvard University
Lecia V. Sequist
Lecia V. Sequist Harvard University
David A. Reardon
David A. Reardon Harvard University
Jennifer S. Temel
Jennifer S. Temel Harvard University
Tracy T. Batchelor
Tracy T. Batchelor Brigham and Women's Hospital
Rameen Beroukhim
Rameen Beroukhim Harvard University
Rakesh K. Jain
Rakesh K. Jain Harvard University
Keith L. Ligon
Keith L. Ligon Harvard University
Alice T. Shaw
Alice T. Shaw Harvard University
Dan G. Duda
Dan G. Duda Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The field of medicine in the USA extends far beyond the traditional MD pathway. Today, a variety of online degrees open doors to rewarding careers in healthcare, offering flexibility for busy students or working professionals.

For those interested in mental health, advanced practice nursing is a rapidly growing area. If you already hold a master's in nursing, you could consider the fastest post master's pmhnp programs, which allow you to qualify as a Psychiatric Mental Health Nurse Practitioner in less time.

Administration is another popular avenue. If cost is a concern, exploring the cheapest online healthcare administration degree options can help you find accredited programs that fit your budget. For those seeking advanced qualifications, understanding the cost of mha degree programs is essential in planning your education expenses.

Aspiring doctoral-level nurses can find high-quality yet cheap online dnp programs to further their clinical expertise. These diverse online pathways make it easier than ever to build a healthcare career tailored to your goals and financial needs.

Best Scientists Citing Alona Muzikansky

Trending Scientists